TrialAntimicrobial agents and chemotherapy2014

Pharmacokinetics and safety of boosted elvitegravir in subjects with hepatic impairment.

Joseph M Custodio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.